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N E U R O S C I E N C E
Locus coeruleus norepinephrine activity mediates 
sensory-evoked awakenings from sleep
Hanna Hayat1, Noa Regev1, Noa Matosevich2, Anna Sales3, Elena Paredes-Rodriguez3,4,5,  
Aaron J. Krom1,6, Lottem Bergman1, Yong Li3, Marina Lavigne7, Eric J. Kremer7, Ofer Yizhar8, 
Anthony E. Pickering3,9, Yuval Nir1,2,10*
A defining feature of sleep is reduced responsiveness to external stimuli, but the mechanisms mediating sensory- 
evoked arousal remain unclear. We hypothesized that reduced locus coeruleus (LC) norepinephrine (NE) activity 
during sleep mediates unresponsiveness, and its action promotes sensory-evoked awakenings. We tested this 
using electrophysiological, behavioral, pharmacological, and optogenetic techniques alongside auditory stimulation 
in freely behaving rats. We found that systemic reduction in NE signaling lowered probability of sound-evoked 
awakenings (SEAs). The level of tonic LC activity during sleep anticipated SEAs. Optogenetic LC activation promoted 
arousal as evident in sleep-wake transitions, EEG desynchronization, and pupil dilation. Minimal LC excitation before 
sound presentation increased SEA probability. Optogenetic LC silencing using a soma-targeted anion-conducting 
channelrhodopsin (stGtACR2) suppressed LC spiking and constricted pupils. Brief periods of LC opto-silencing 
reduced the probability of SEAs. Thus, LC-NE activity determines the likelihood of sensory-evoked awakenings, 
and its reduction during sleep constitutes a key factor mediating behavioral unresponsiveness.
INTRODUCTION
Sleep is characterized by a reversible disconnection from the en-
vironment that entails reduced responsiveness to external stimuli. 
An elevated arousal threshold is a central feature of sleep that is 
present in all mammals and constitutes the main criterion by which 
sleep is defined in species lacking cortical electroencephalography 
(EEG) such as reptiles, nematodes, flies, and fish, and even in jelly-
fish without a central nervous system (1). Thus, understanding 
how sleep is maintained in the face of external sensory events and 
what determines sensory-evoked awakening is an open question. 
Naturally, the intensity of sensory stimuli affects awakening prob-
ability (2), but other factors such as behavioral relevance also play 
a role. For example, vocalizing a person’s name is more likely to 
produce awakening compared to a meaningless stimulus of equal 
intensity (3). Apart from the properties of sensory stimuli, the 
internal state also plays a role. For example, arousal thresholds 
depend on sleep stage [non-rapid eye movement (NREM) sleep versus 
rapid eye movement (REM) sleep], sleep duration, and slow-wave 
activity (SWA) (2). In addition, arousal thresholds vary substantially 
between individuals and with age (4): While some individuals 
experience hyperarousal (e.g., chronically or during transient anx-
iety) and wake up frequently from weak stimuli, others sleep deeply 
and only high-intensity stimuli lead to awakenings. What deter-
mines sensory- evoked awakening and the factors underlying vari-
ability across individuals, age, and throughout sleep remain largely 
unknown.
Wakefulness is supported by a number of subcortical wake- 
promoting neuromodulatory systems (5). Multiple studies established 
that levels of norepinephrine (NE), serotonin, histamine, and hypocretin 
(orexin) are high during wakefulness and low during both NREM 
and REM sleep, whereas acetylcholine levels and dopaminergic levels 
(in the ventral tegmental area and in the ventral periaqueductal gray 
matter) are high during both wakefulness and REM sleep and 
decrease during NREM sleep (5, 6). Recent studies established a causal 
relationship between neuromodulatory activity and awakenings. 
For example, optogenetic activation of hypocretin neurons in 
the lateral hypothalamus (7), noradrenergic neurons in the locus 
coeruleus (LC) (8, 9), and dopaminergic neurons in the dorsal raphe 
nuclei (10) increases the probability of sleep-to-wake transitions. 
Activating GABAergic neurons from the lateral hypothalamus or 
dopaminergic neurons in the ventral tegmental area induces rapid 
awakening from NREM, but not REM sleep (11, 12). However, these 
experiments focused on internally triggered sleep-to-wake transi-
tions, and it remains unclear whether the same systems also mediate 
sensory-evoked awakenings.
We hypothesized that the LC-NE system plays a key role in 
mediating sensory-evoked arousals and that its reduced activity 
throughout sleep contributes to unresponsiveness. Several lines of 
evidence support this proposition: First, LC activity was found to be 
high during wakefulness, low during NREM sleep, silent during 
REM sleep, and to increase before sleep-to-wake transitions in rats 
(13). Second, LC activation leads to EEG activation in anesthetized 
rats (14) and immediate awakening from sleep (8, 9)—within few 
seconds—whereas activation of hypocretin neurons leads to an 
awakening with latencies around 25 s (7), and those are likely medi-
ated via LC projections (15). Third, LC-NE activity is implicated in 
orienting responses and in responding to salient behaviorally rele-
vant stimuli (16) and is involved in stress and pain processing that 
affects arousals and awakenings (17, 18). Fourth, LC-NE modulates 
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the signal-to-noise ratio in sensory systems (19). Fifth, a higher 
arousal threshold is found in NE-deficient mice after sleep depriva-
tion (20), and low NE levels during wakefulness are associated with 
electrophysiological markers of disengagement from the environment 
such as high-voltage spindles (21). Given these considerations, we 
set out to test the causal role of LC-NE activity in mediating sensory 
disconnection during sleep.
We performed a series of experiments in rats, focusing on auditory 
stimulation during natural sleep where we controlled sensory stim-
ulation with high temporal resolution. After establishing an experi-
mental system to quantify auditory arousal thresholds from natural 
sleep, we pharmacologically manipulated NE signaling, finding that 
lower NE signaling reduced awakening probability. Next, we recorded 
LC spiking activity during natural sleep and found that baseline 
tonic LC activity was higher before sounds that produced awaken-
ings. To test the causal role of LC-NE activity in more detail, we 
established selective and efficient optogenetic control over LC 
activity, including the use of a new vector to silence the LC. Both 
optogenetic excitation and silencing reliably controlled LC activity 
and bidirectionally modulated pupil size. We then delivered sounds 
during natural sleep in conjunction with either minimal LC exci-
tation or with LC silencing, finding that LC-NE activity is sufficient 
(and necessary) to modulate the probability of awakening in re-
sponse to sound.
RESULTS
Attenuation of NE signaling decreases the probability 
of sound-evoked awakening
We first established and validated an experimental protocol to reliably 
quantify auditory arousal threshold in freely sleeping rats. We con-
tinuously monitored the vigilance state via EEG, electromyography 
(EMG), and video as animals spontaneously switched between wake-
fulness and sleep. In each experiment lasting 10 to 12 hours, hundreds 
of tone pips were intermittently presented with long interstimulus in-
tervals, and for each trial, we determined whether the stimulus led to an 
awakening or sleep was maintained (Fig. 1A, fig. S3, and Materials and 
Methods). The probability of sound-evoked awakening (SEA) mono-
tonically increased with sound intensity levels and also depended 
on sleep stages whereby REM sleep was associated with higher SEA 
probability (Fig. 1B). Two-way analysis of variance (ANOVA) revealed 
significant main effects of both sound intensity (P = 3.29 × 10−15) 
and sleep stage (P = 0.028, n = 4 rats). The increase in awakening prob-
ability as a function of sound intensity established that arousal threshold 
can be quantified in a sensitive and reliable manner using this ap-
proach. In addition, we find higher EEG SWA (0.5 to 4 Hz power) 
in prestimulus baseline (2 s before sound onset) before trials not fol-
lowed by behavioral awakenings (fig. S3G), as previously shown (2).
We then evaluated SEA probability after manipulating NE signal-
ing with drugs affecting the 2 adrenoceptor [whose primary effect 
Fig. 1. Lower NE signaling decreases the probability of SEAs from NREM sleep. (A) Representative EEG and EMG traces showing immediate awakenings (top) versus 
maintained sleep (bottom) after auditory stimulation (4-kHz pure tone, 1-s duration; orange bars) in NREM sleep (left) and REM sleep (right). (B) Probability of awakenings 
(%) as a function of sound intensity in NREM sleep (purple) and REM sleep (dark blue). Gray circles show individual subject data (n = 4 rats). (C) Schematic of experimental 
setup for rat arousal threshold experiments (each lasting ~12 hours during lights on periods, with ~400 tone pips presented every 105 s on average). Sounds were delivered 
intermittently from speaker on top, while animals were continuously monitored with EEG, EMG, and video. In pharmacological experiments, NE drugs were injected 
intraperitoneally at lights on (10:00 a.m.). (D) Probability of awakenings (%) as a function of sound intensity in NREM sleep following administration of detomidine 
(2 agonist, lower NE; green), yohimbine (2 antagonist, higher NE; blue), or saline (gray). Note that lower NE decreases awakening probability. Two-way repeated-measures 
(RM) ANOVA, followed by post hoc t tests corrected with false discovery rate (FDR) *P < 0.05 and **P < 0.01 in n = 6 rats.
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is suppression of NE release via autoreceptor negative feedback; 
(22)]. We injected either detomidine (2 agonist, to decrease NE 
signaling; 1 mg/kg), yohimbine (2 antagonist, to increase NE signal-
ing; 1 mg/kg), or saline (control) intraperitoneally to each animal in 
separate experiments performed on different days with order coun-
terbalanced (Fig. 1C). We first evaluated the effects of modulating 
NE signaling on sleep architecture and locomotor activity (fig. S1). 
Detomidine increased the time spent in NREM sleep at the expense 
of wakefulness and REM sleep (20.2 ± 1.1% increase in NREM 
sleep, n = 6 rats; fig. S1B). Yohimbine did not significantly affect 
sleep architecture but did increase locomotor activity during the 
first 3 hours (fig. S1, D and E). Next, we evaluated SEAs after NE 
drug injections. Detomidine decreased the probability of SEA 
during NREM sleep [14.1 ± 3.4%, 24.8 ± 5.0%, and 46.1 ± 7.3% 
decrease for 76-, 88-, and 98-dB SPL (sound pressure level) sound 
levels, respectively; n = 6 rats] (Fig. 1D and fig. S1A). Yohimbine 
did not affect the probability of SEA. Although this systemic pharma-
cological manipulation has some caveats given the widespread actions 
of 2 adrenoceptor agonists, this supported the suggestion that 
attenuating NE signaling decreases the probability of SEA.
Baseline tonic LC activity reflects probability of SEA 
from NREM sleep
To determine whether ongoing changes in LC activity predict SEAs 
during sleep, we recorded the spiking of LC neurons (n = 16 neuronal 
clusters from three rats) using chronically implanted, drivable silicon 
probes in freely behaving animals. LC neurons were identified by 
their typical action potential waveforms and their “biphasic” re-
sponses to toe pinch (Fig. 2A). We found that mean spike discharge 
rates were highest during active wakefulness, lower during quiet 
wakefulness, and lowest in sleep (Fig. 2B), as previously reported 
(13). We did not observe differences in LC firing rates between 
NREM sleep and REM sleep, possibly due to our multiunit recordings. 
The lowest firing rates were observed during NREM-to-REM tran-
sitions, when sleep spindle activity is maximal (23, 24). Many (56%, 
9 of 16) LC clusters reliably responded to auditory stimulation by 
firing brief phasic bursts shortly after sound onset, which showed 
an opposite trend relative to tonic baseline firing (phasic response: 
active wake < quiet wake < NREM sleep, n = 9 clusters; Fig. 2C). 
Dividing auditory trials during NREM sleep to those that ultimately 
led to an awakening or not (Fig. 2, D and E), we found that LC spiking 
Fig. 2. Baseline tonic LC activity is higher before SEAs from NREM sleep. (A) Two representative LC clusters recorded during the experiment. Left: Action potential 
waveforms of unit clusters. Right: Corresponding raster plot and peristimulus time histogram (PSTH) in response to toe pinch under light anesthesia. (B) Average 
spontaneous firing rates of LC clusters (n = 16 from three rats) across different sleep-wake states, one-way RM ANOVA followed by post hoc FDR-corrected t test 
(***P < 0.001 and *P < 0.05). (C) Phasic LC response to sound (0 to 100 ms after sound onset) in 9 of 16 LC neurons exhibiting auditory-evoked discharges as a function of 
vigilance state. Mean ± SEM across n = 9 clusters, one-way RM ANOVA followed by post hoc FDR-corrected t-test; *P < 0.05 and **P < 0.01. (D) Representative auditory- 
evoked multiunit (MU) firing (raster and PSTH) during NREM sleep. Left: Trials followed by awakening. Right: Trials followed by maintained sleep. Horizontal orange bar 
shows 1-s tone stimulus. (E) Quantification of baseline LC activity during NREM sleep in trials preceding awakening (light purple) versus maintained sleep (dark purple). 
Data represent means ± SEM (**P < 0.01, paired t test; n = 16 neuronal clusters, an average of 84 trials per cluster, n = 3 rats). Note significantly higher baseline activity before 
awakenings (51.37% increase compared with maintained sleep).
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activity before sound onset was significantly higher (P < 0.01 via 
paired t test) before trials that led to awakening (1.4 ± 0.4 Hz) versus 
maintained sleep (0.95 ± 0.3 Hz). By contrast, the phasic response 
(0 to 100 ms after sound onset) was not linked with SEA probability 
during NREM sleep (P = 0.96, paired t test; n = 9).
Optogenetic LC excitation elicits behavioral, 
electrophysiological, and pupillary signs of arousal
To achieve cell type–specific optogenetic control over LC activity, 
we unilaterally transduced LC neurons by injecting CAV2-PRS-
ChR2-mCherry (Fig. 3A). Transgene expression was specific and 
effective, where 100% of the mCherry-positive neurons coexpressed 
tyrosine hydroxylase (TH) and 83 ± 3.4% of TH+ neurons coexpressed 
mCherry (Fig. 3B). Next, we verified optical activation of LC neurons 
in vivo under light anesthesia. We implanted a 16-channel optrode 
and recorded LC firing activity in neurons in the dorsal pons, which 
exhibited characteristic wide action potentials and responded to both 
toe pinch (Fig. 3D) and laser stimulation (Fig. 3, E to I). Upon laser 
illumination, we found reliable activation of LC neurons that showed 
a clear relationship between firing rate and illumination parameters 
including light intensity, pulse duration, and stimulation frequency. 
Although a subset of LC neurons may not respond to toe pinch (25), 
in our hands, neurons that responded to laser stimulation showed 
toe pinch–evoked firing, which had a typical biphasic response to 
contralateral and ipsilateral pinch (Fig. 3D) (17, 26).
In freely behaving rats, strong (10 s at 10 Hz, 90-ms pulse duration) 
LC activation reliably led to awakenings from NREM sleep and to 
EEG activation, in line with previous studies (8, 9) (Fig. 3C). The 
ability to elicit short arousals upon unilateral LC optogenetic activa-
tion was maintained for 6 months, attesting to sustained and stable 
canine adenovirus type 2 (CAV2)–mediated ChR2 expression with 
minimal toxicity [as previously noted; (9)], also validated by immuno-
histochemistry (Materials and Methods).
Next, we asked whether LC opto-activation alters pupil size. Under 
light anesthesia, LC opto-activation (3-s stimulation, at 10 Hz) 
induced a large increase in pupil size (32.38, 65.03, 93.26, 127.57, and 
177.30% increase compared with baseline for 10-, 30-, 50-, 70-, and 
90-ms illumination pulse durations, respectively; Fig. 3,  J  to L, 
and movie S1). Together, these data demonstrate that optogenetic 
LC excitation elicits reliable behavioral, electrophysiological, and 
pupillary markers of arousal.
Minimal optogenetic LC excitation increases probability 
of SEAs during NREM and REM sleep
To examine the causal effects of LC activity on arousal threshold 
during sleep, we combined LC optogenetic activation with auditory 
stimulation. Pupil dilation (under light anesthesia) and awakenings 
during NREM sleep from adequate opto-activation were prerequisites 
for inclusion of rats in the in vivo auditory arousal threshold ex-
periments. For each animal, we first titrated laser stimulation to 
identify a minimal level that was insufficient on its own to elicit 
reliable awakenings (by shortening stimulation duration to 3 s and 
shortening individual pulse duration to 10 or 30 ms; see Materials 
and Methods). Next, during the arousal threshold experiment, tone 
pips were delivered at 67- and 80-dB SPL. In half of auditory trials, 
sounds were presented on a background of minimal laser illumina-
tion. In addition, laser was activated in the absence of sound to 
evaluate the effect of the laser alone. We then compared awaken-
ing probability in sound-only trials (“S”), laser-only trials (“L”), 
and their co-occurrence (“SL”) (Fig. 4A). LC activation increased 
awakening probability (29.8 ± 5.9% and 25.3 ± 8.3% increase from 
NREM sleep and REM sleep, n = 8 rats and n = 6 rats, respectively; 
Fig. 4, B and C, and fig. S2). This increase was greater than that ex-
pected, assuming independent effects of LC activation and auditory 
stimulation (yellow bars in Fig. 4 and fig. S2; Materials and Methods). 
We found a change in SEA probability for all stimulation regimes 
(5 Hz, 10 Hz, or “phasic mode” in Materials and Methods; fig. S2). 
Because sleep spindles are associated with higher arousal threshold 
during NREM sleep (27, 28), we analyzed their occurrence during 
minimal LC excitation associated with increased SEA probability. 
LC optogenetic activation (at 10 Hz) before sounds presented 
during NREM sleep decreased spindle occurrence (0.052 spindles/s 
versus 0.036 spindles/s for “laser off” and “laser on” trials, respectively; 
n = 8 rats, P = 0.017 via one-tail paired t test), in agreement with 
previous studies (13, 24).
Optogenetic silencing with an anion-conducting 
channelrhodopsin effectively suppresses LC neuronal 
activity and causes pupil constriction
Multiple wake-promoting systems can lead to sleep-wake transitions, 
and as we have seen, selective LC-NE activity is sufficient to increase 
probability of SEA. But, does selective silencing of this system alone 
during sleep decrease SEAs? In other words, is LC-NE activity necessary 
to modulate arousal threshold? To address this, we specifically and 
efficiently silenced the LC with high temporal resolution using a 
CAV2 vector harboring a soma-targeted anion-conducting opsin 
stGtACR2 (29) under the control of the PRS promoter (CAV2-PRS-
stGtACR2-fRed). After bilateral LC injections, we observed specific 
transgene expression in the LC, where 100% of the fusionRed 
(fRed)–positive neurons coexpressed dopamine -hydroxylase (DBH) 
and 31 ± 9.6% DBH+ neurons coexpressed fRed (Fig. 5A).
To evaluate the functional effects of stGtACR2 on LC neurons 
in vitro, we transduced rats (p21) unilaterally with CAV2-PRS- 
stGtACR2-fRed and, 2 to 3 weeks later, prepared acute pontine slices 
for whole-cell patch-clamp recordings. Recordings from transduced 
LC neurons (n = 14) showed that opto-activation of stGtACR2 
silenced spontaneous firing by activating a potent shunting con-
ductance that reversed close to the calculated chloride reversal 
potential (fig. S5). This was capable of blocking action potential 
discharge evoked by intracellular current injection (driving firing 
to ~15 to 20 Hz) with rapid onset and offset (Fig. 5B).
To stringently test the effectiveness of the stGtACR2 silencing 
strategy in vivo, we transduced adult rats unilaterally with a rela-
tively low titer of CAV2-PRS-stGtACR2-fRed [1.4 × 107 physical 
particles (pp)] and, 3 to 4 weeks later, recorded LC action poten-
tial discharge under urethane anesthesia with a 32-channel silicon 
probe. Laser illumination of the LC, delivered via a separate optic 
fiber (445 nM, 10 mW at end of fiber), strongly silenced neurons, 
including during trials when paw pinches or foot shocks were deliv-
ered (Fig. 5, C and D).
Such LC opto-silencing led to robust pupil constriction even 
during light anesthesia, when pupils are already constricted at base-
line. Continuous bilateral laser stimulation decreased pupil size 
compared with baseline (8.2 ± 3.66% and 14.9 ± 6.9% decrease for 
3- and 10-s laser pulses, respectively; n = 6; Fig. 5, E and F). Pupil 
constriction was parametrically dependent on laser stimulus dura-
tion, whereby longer illumination (10 s versus 3 s) led to a larger 
effect (P < 0.05). The average time to nadir was 3.14 ± 0.28 s after 
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Fig. 3. Specific and effective optogenetic excitation of LC neurons. See caption on the following page.
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laser onset for 3-s stimulation and 9.26 ± 0.79 s for 10-s stimulation. 
Thus, CAV2-mediated expression of stGtACR2 allows effective 
opto-silencing of LC neuronal activity, which causes pupil 
constriction.
Optogenetic LC silencing decreases probability of SEA 
from NREM sleep
To assess whether LC silencing affects arousal thresholds during 
sleep, we combined LC optogenetic silencing via stGtACR2 with 
auditory stimulation. To ensure effective LC silencing in each 
animal, pupil constriction in both eyes (under anesthesia as above) 
was a prerequisite for in vivo auditory arousal threshold experiments. 
Laser stimulation was applied for 5 s continuously to avoid effects of 
rebound activity upon silencing termination (5 to 7 mW at the end of 
the fiber), either simultaneously with the sound (SL) or—motivated 
by the difference in baseline tonic effects noted previously (Fig. 2)—
starting 2 s before sound onset (SafterL; Fig. 6A). LC silencing in-
creased EEG SWA in NREM sleep (fig. S3H), as was reported for LC 
silencing during wakefulness (8). SEA probability during NREM 
sleep (but not REM sleep) decreases in both conditions (4.38 ± 2.01% 
Fig. 4. Minimal optogenetic LC excitation increases the probability of SEAs. (A) Left: Schematic of three conditions in LC optogenetic activation arousal threshold 
experiments: presentation of sound (S) only, sound on a background of blue laser stimulation (SL), and blue laser only (L). Right: Schematic of experimental session for rat 
arousal threshold experiments combined with LC optogenetics (each experiment lasting ~12 hours during lights on periods, with hundreds of tone pips presented every 
55 s on average). (B) Probability of awakening in NREM sleep as a function of the three experimental conditions in rats injected with CAV-PRS-ChR2-mCherry (blue, 
n = 8 rats) or control mCherry (gray, n = 6 rats). Yellow horizontal line dividing the SL bar represents the expected independent effect of sound and laser stimulation 
(Materials and Methods). n.s., not significant. (C) Same as in (B) for REM sleep with rats injected with CAV-PRS-ChR2-mCherry (blue, n = 6 rats) or control mCherry 
(n = 6 rats; gray). **P < 0.01 and *P < 0.05, paired t tests corrected with FDR (see fig. S2 for laser frequency parameters). On average, per session and for each condition 
(SL/S/SL), n = 68 trials occurred during NREM sleep, and n = 21 trials occurred during REM sleep.
Fig. 3. Specific and effective optogenetic excitation of LC neurons. (A) Schematic of unilateral LC injection and optic fiber implantation. (B) Specific expression of 
ChR2-mCherry in LC neurons: Representative coronal images showing CAV2-PRS-ChR2-mCherry expression (left column, red), labeling of TH+ neurons (middle column, 
green), and their overlay (right column, yellow). Top: Global expression in coronal sections; middle: expression around the LC; bottom: magnified images of cells in the 
boxed area marked in middle row. Arrows mark neurons showing coexpression. (C) Top: Representative EEG and EMG traces showing an immediate awakening from 
NREM sleep upon strong optogenetic LC activation (10-s stimulation at 10 Hz, 90-ms pulses). Bottom: Representative EEG spectrograms after LC activation (bottom left) 
versus no laser stimulation (bottom right). (D) Representative recordings from two LC neurons recorded simultaneously. Insets show action potential waveforms, while 
raster plots and PSTHs show typical biphasic response to contralateral and ipsilateral toe pinch. (E) Top: Representative high-pass–filtered (>300 Hz) traces of two simul-
taneously same recorded channels in response to 1 Hz on/off laser stimulation. Middle and bottom: Raster plot and PSTH of neuron from bottom trace. (F) Same as in (E) 
for stimulation at 5 Hz (pulse duration, 10 ms). (G) Same as in (E) for laser stimulation at 10 Hz (pulse duration, 10 ms). (H) Laser-evoked firing rate as a function of light 
intensity (left; 1-s stimulation), pulse duration (middle; at 5 Hz), or stimulation frequency (right; pulse duration, 10 ms). (I) Significant increase in LC firing rates upon 1-s 
laser illumination compared with baseline (***P < 0.001, paired t test; n = 7 neuronal clusters from two rats, 37 trials, on average, per unit). (J) Representative single trial 
example of LC optogenetic induced pupil dilation. Top: Video images and pupil size estimation (red contour) before and during 3-s laser illumination (10 pulses/s, 90-ms 
pulse duration). (K) Fifteen-second time courses of pupil size increase (relative to baseline) for five pulse duration conditions (10 to 90 ms, light to dark blue) in each 
animal. (L) Summary data (mean ± SEM) of pupil size increase as a function of laser pulse duration (**P < 0.01 and *P < 0.05, Wilcoxon test) in n = 6 rats (ChR-mCherry; blue) 
and n = 6 control rats (mCherry; gray). Five to 15 trials per pulse duration condition.
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Fig. 5. Specific and effective optogenetic inhibition of LC neurons. (A) Schematic of bilateral LC injection and optic fiber implantation (top) and specific expression of 
stGtACR2-fRed in LC neurons (bottom): representative coronal images showing CAV2-PRS-stGtACR2-fRed expression (left column, red), labeling of DBH+ neurons (middle 
column, green), and their overlay (right column, yellow). (B) Whole-cell current-clamp recording from LC neurons in pontine slice (n = 10 rats, one to three neurons per 
rat) showing the spike discharge evoked by current injection is prevented by a brief pulse of light (473 nm, 200 ms x 4 mW) to activate the stGtACR2, a silencing effect 
seen across recordings from transduced LC neurons (data from response to 175-pA pulse; P = 0.002, Wilcoxon matched pairs; n = 10 neurons), whereas no effect of light 
was seen in nontransduced LC neurons in the same slices (n = 7 neurons). (C) Representative data from two recordings of neuronal clusters in the same CAV2-PRS-
stGtACR2-fRed transduced rat. (Left) Action potential waveforms, (middle) raster plots and PSTH of inhibitory responses to different laser durations (in blue, 200, 1000, 
and 5000 ms), and (right) LC neuron with typical biphasic response to contralateral toe pinch, abolished by concurrent illumination. (D) Bar graph shows significant 
decrease in the firing rate of LC neurons upon 1 s of laser illumination (n = 13 units from two rats; nine trials, on average, per unit; ***P < 0.001, paired t test). (E) Representative 
pupil size traces (gray lines represent single trials, and black lines represent average of the trials) during 3 s (left) and 10 s (right) of laser illumination. (F) Bar graph shows 
significant pupil constriction when LC was silenced in a duration-dependent manner (stGtACR2 in blue, n = 6 rats; control mCherry in gray, n = 5 rats, 5 to 15 trials per laser 
duration condition), *P < 0.05, Wilcoxon test.
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and 8.59 ± 2.10% decrease for SL and SafterL, respectively; n = 6) with 
a more pronounced decrease when baseline LC activity was silenced 
before sound onset (Fig. 6, B and C). Unlike the association between LC 
excitation and reduced spindles, LC silencing did not significantly 
affect spindle occurrence, although there was a trend toward increased 
spindle events (P = 0.068 via one-tailed paired t test; n = 6).
DISCUSSION
Behavioral unresponsiveness is a major characteristic of sleep that 
persists despite the danger it presents (predation). However, little is 
known about the neural mechanisms that mediate reduced respon-
siveness in the face of external sensory events and what underlies 
the variability in SEA probability between species and between in-
dividuals. Here, we show the role of LC-NE activity in mediating 
sensory-evoked arousal threshold during sleep. After validating 
an experimental paradigm to quantify auditory arousal threshold in 
freely sleeping rats, we tested the link between LC-NE activity and 
SEAs. We established a relationship between baseline tonic LC 
activity and the probability of SEA and found that pharmacologically 
decreasing NE signaling reduced SEA probability. Minimal opto-
genetic LC excitation increased SEA probability during both NREM 
and REM sleep, while optogenetic silencing decreased SEA proba-
bility during NREM sleep, especially when silencing began shortly 
before sound onset. These results causally link activity in the LC to 
sensory stimulus–evoked awakening and support the idea that the 
absence of LC activity during sleep is responsible for the elevation 
of arousal thresholds.
Mechanisms controlling sensory-evoked awakening
Multiple overlapping neuromodulatory systems are implicated in sleep- 
wake regulation, including noradrenaline, histamine, acetylcholine, 
Fig. 6. Optogenetic LC silencing decreases the probability of SEAs. (A) Schematic of three conditions in LC opto-silencing arousal threshold experiments. Top: 
Presentation of sound (S) only (85-dB SPL); middle: same sound played simultaneously with laser stimulation (SL); bottom: same sound played 2 s after laser onset 
(SafterL). Laser duration was continuous for 5 s. (B) Probability of awakening as a function of the three conditions in rats expressing stGtACR2-fRed (blue, n = 6 rats) and 
mCherry control (gray, n = 5 rats) in NREM sleep (left) and REM sleep (right) (*P < 0.05 and **P < 0.01, paired t test). (C) Probability of awakenings from NREM sleep in each 
session per rat expressing stGtACR2-fRed. On average, per session and for each condition (S/SL/SafterL), 71 trials occurred during NREM sleep, and 20 trials occurred 
during REM sleep.
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hypocretin, and dopamine (5, 6). Strong activation of any of these 
systems promotes arousal, whereas their inhibition reduces wakefulness. 
Our results present several previously unknown findings. They go 
beyond neuromodulatory mechanisms controlling spontaneous 
awakening and highlight a key role for the LC-NE system in mediat-
ing sensory- evoked awakening in a natural context. Moreover, LC-NE 
activity modulates arousal threshold during sleep in a graded proba-
bilistic manner. Given the overlap in neuromodulatory activities, 
other mechanisms likely also contribute to this process, as was 
shown for dorsal raphe dopamine activity (10). Wakefulness does not 
depend on one exclusive system, because even simultaneous 
lesions of histaminergic, noradrenergic, and cholinergic neurons do 
not robustly affect daily levels of wakefulness (30). Given that being 
able to wake up in response to external stimuli is crucial for survival, 
overlapping mechanisms likely contribute.
The mechanisms downstream from LC that modulate SEAs re-
main unclear. Our optogenetic experiments targeted LC cell bodies, 
and future studies are needed to determine the roles of NE (and 
dopamine) release at specific projection targets. While LC has been 
typically regarded as a relatively homogeneous nucleus, some recent 
studies challenge this view and suggest that LC subpopulations have 
distinct projections that serve different functions (31). Downstream 
effects of LC on SEAs could be mediated through direct cortical 
projections, where -adrenergic receptors mediate cortical de-
synchronization (32). The LC may also act through thalamic projections. 
Infusion of NE (or LC stimulation) increases thalamic excitability, 
suppresses ongoing rhythmic activity (32), and accelerates emergence 
from anesthesia (33). Other possibilities are that LC affects regions 
that promote motor output or other modulatory centers such as the 
basal forebrain, where it activates cholinergic wake-promoting neurons 
and inhibits GABAergic sleep-promoting neurons. Infusion of -or 
1-receptor agonists into the basal forebrain causes SWA suppression 
and promotes awakening (34). LC projections to the hypothalamus, 
the amygdala, or other regions could also be involved.
A causal link between LC activity and pupil size
Pupil size is a marker of arousal and is often used to indirectly infer 
LC-NE activity levels across multiple species (35). Pupil size is tightly 
correlated with LC activity in monkeys (36, 37) and humans (38) 
and with cortical noradrenergic activity in mice (39, 40). In addition, 
electrical stimulation of LC causally affects pupil size (36, 41). Here, cell 
type–specific LC optogenetic establishes a robust causal bidirectional 
influence of LC activity on pupil size. Under light anesthesia, LC 
optogenetic activation drives large pupil dilation, while optogenetic 
silencing causes a modest but consistent pupil constriction, possibly 
reflecting a “floor” effect related to anesthesia. Our results in rats 
support a recently published study in mice (40) in showing that LC 
activity is sufficient to bidirectionally alter pupil dilation. LC-mediated 
pupil dilation may act through disinhibition of parasympathetic 
pathways (e.g., via cholinergic preganglionic neurons of the Edinger- 
Westphal nucleus controlling the sphincter muscle) with possible 
contribution of sympathetic pathways controlling the iris dilator 
muscle (41, 42). Our results provide a robust experimental frame-
work to explore the precise mediating pathways in detail.
Tonic and phasic LC activity
The LC shows two types of activity: a tonic mode that is high in 
wakefulness and low in sleep implicated also in arousal, stress, anxiety, 
and pain processing, and a phasic mode that occurs during presen-
tation of salient stimuli, behavioral tasks, and reward anticipation 
(43). Our results highlight a role for tonic (but not phasic) LC activity 
in SEAs. For example, SEA probability was lower when LC silencing 
started before sound presentation than when LC silencing began 
simultaneously with the sound (Fig. 6B). In contrast, phasic sound-
evoked LC responses were not linked to SEAs and were inversely 
proportional to levels of baseline tonic LC firing. The link between 
tonic LC activity and SEAs observed here, together with the link 
between tonic LC activity and anxiety (18), suggests how anxiety 
may promote awakenings (44). An active inference model recently 
proposed that LC activity represented a state-action prediction 
error where uncertainty was reflected in increased LC activity, 
which, in turn, promoted behavioral flexibility in behaving agents 
(45). This may be extended to sleep states where the observed tonic 
LC activity represents uncertainty about internal state and influences 
the probability of response (awakening) to a sensory stimulus 
(sound). Along this line, LC-NE activity may be an important factor 
driving variability in arousal threshold across individuals. We were 
surprised that phasic LC activity was not related to SEA probability, 
because it is reported to be related to salient stimuli. Thus, the 
mechanisms that underlie more frequent awakening in response to 
behaviorally relevant stimuli remain to be elucidated (3). While the 
current results indicate that LC activity robustly modulates SEA, it 
remains unclear to what extent this co-occurs with corresponding 
response modulations along sensory pathways. While LC-NE sig-
naling modifies response fidelity across sensory modalities and 
species (43), it is unlikely that lower LC-NE activity simply “gates” 
propagation of auditory signals to the cortex, because auditory 
responses in primary cortex are largely comparable across vigilance 
states (46–48). Instead, tonic LC activity that drives SEAs may 
facilitate sensory processing downstream from primary regions by 
acting at higher-order regions or nonsensory pathways to promote 
awakenings.
In summary, we show that low LC activity during sleep plays a 
key role in mediating reduced responsiveness to sensory stimuli, 
thereby revealing a mechanism that controls how sleep is main-
tained in the face of external events.
MATERIALS AND METHODS
Animals
All experimental procedures at the University of Tel Aviv including 
animal handling, surgery, and experiments followed the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals 
and were approved by the Institutional Animal Care and Use 
Committee. All experimental procedures at the University of 
Bristol conformed to the UK Animals (Scientific Procedures) Act 
1986 and were approved by the University Animal Welfare and 
Ethical Review Board. Adult male Long-Evans rats (supplier, e.g., 
Rat Resource & Research Center, 8 to 12 weeks old at the time of 
surgery) were used for arousal threshold, pharmacological, and 
optogenetic experiments, except for acute opto-silencing where 
adult Lister Hooded rats were used (supplied by Charles River, 9 to 
12 weeks old at time of surgery). Adult male Wistar rats (supplier 
Harlan Israel, 8 to 12 weeks old at the time of surgery) were used for 
chronic recordings. Rats were housed individually in transparent 
Plexiglas cages at constant temperature (20° to 23°C), humidity 
(40 to 70%), and circadian cycle (12-hour light/dark cycle, start-
ing at 10:00 a.m.). Food and water were available ad libitum. 
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All behavioral and electrophysiological experiments were performed 
between 10:00 a.m. and 10:00 p.m. A few days before surgery, rats 
were placed in their home cage for habituation to the experimental 
environment.
Viral vectors
Viral vectors included CAV2-PRS-hChR2(H134R)-mCherry for LC 
opto-excitation (9) and CAV2-PRS-stGtACR2-fRed [for LC opto- 
silencing—based on (29)]. CAV2 vector titers were between 5 × 1012 
and 14 × 1012 physical particles (pp)/ml, and 1 x 109 pp were typically 
injected to the LC. The generation and validation of CAV2-PRS-
ChR2-mCherry for selective LC opto-excitation are described in 
our previous work (9). In brief, a 240–base pair PRSx8 synthetic 
promoter sequence was used that restricts the expression of the 
transgene to a subset of neurons that express the Phox2 transcrip-
tion factor, which are predominantly catecholaminergic. For control 
animals, a double injection of CAV2-PRS-Cre-V5 (×10 dilution) and 
AAV5-EF1a-DIO-mCherry (Viral Core Facility, University of 
Zurich) was performed in a 1:1 ratio (fig. S4). mCherry+ neurons 
(95.4 ± 2.9%) coexpressed TH, and 24.8 ± 8.0% of TH+ neurons 
were mCherry+. CAV2-PRS-stGtACR2-fRed was generated using 
methods described in (49). Details of the construction are available 
upon request: Briefly, CAV2-PRS-stGtACR2-fRed contains the PRS 
promoter driving stGtACR2 in sequence with fRed, a monomeric 
fluorescent protein, and a poly-adenylation signal (polyA) from SV40. 
This cassette replaces the E1 region in a E1/E3-deleted, replication- 
defective CAV vector. Similarly, CAV2-PRS-Cre-V5 was generated 
in the Pickering Lab and has the same promoter with Cre recombinase 
and a V5 tag in the expression cassette.
Surgery
Before all surgical procedures, rats were anesthetized [with either 
isoflurane 4% by volume for induction and 1.5% for maintenance or with 
ketamine (50 g/kg; Vetalar; Pharmacia, Sweden) and medetomidine 
(300 mg/kg; Domitor; Pfizer, UK)] and placed in a stereotaxic frame. 
Surgery was performed under sterile conditions, following procedures 
described in (47, 50). Under microscopic control, a craniotomy was 
made using a high-speed surgical drill. When a probe/optrode was 
implanted, the dura was carefully opened. Then, electrodes or injec-
tion needles were advanced into the brainstem after penetrating the 
pia mater while carefully avoiding vasculature. Two-component 
silicone gel (Kwik-Sil; World Precision Instruments, FL, USA) was 
applied to seal the craniotomy and protect the brain surface. After 
gel polymerization, dental acrylic was gently placed around the 
electrodes or optic fibers, fixing them to the skull. EEG screws were 
placed over the frontal and parietal cortices. Ground and reference 
screw electrodes were placed above the posterior parietal lobe (ChR2 
and associated experiments as well as chronic LC recordings) or 
above the cerebellum (otherwise). Neck muscle electrodes were 
implanted bilaterally, and bipolar referencing was used for EMG. A 
custom-made EEG/EMG connector was fixed on the skull with 
dental cement for sleep recordings.
For all experiments (except for acute silencing recordings), viral 
vectors were injected to the LC (using a UMP3 Microsyringe Injector 
and a Micro4 Controller pump, and 33-gauge NanoFil needles 
World Precision Instruments, USA) unilaterally (for activation) or 
bilaterally (for silencing) at the following coordinates: anteroposterior 
(AP),  −3.7 mm; mediolateral (ML), ±1.18 mm; dorsoventral (DV), 
6.2 to 6.6 mm with rostral angulation of 15°; and at a rate of 100 nl/min 
for 12 min (three injections of 400 nl for a total volume of 1.2 l). 
For light stimulation/inhibition, an optic fiber [200-m diameter, 
0.22 numerical aperture (NA)] was implanted (MFC_200/240-
0.22_10 mm_MF1.25_FLT, Doric Lenses) above the LC. Unilateral 
and bilateral fiber implants were used for LC opto-excitation and 
opto-silencing, respectively, as was the case for virus injections, at 
these coordinates: AP,  −3.7 mm; ML, +1.21 mm; DV, 5.4 mm with 
rostral angulation of 15°). In acute silencing experiments, viral vector 
was injected to the LC (using a Neurostar injector-drill robot on a 
Kopf stereotaxic frame) at the following coordinates: AP,  −2.1 mm; 
ML, +1.2 mm; DV, 5.3 to 5.8 mm with rostral angulation of 10°.
Electrophysiology and LC recordings
Brain slice recordings
Male Wistar rats were used for slice electrophysiology using previ-
ously described methods (17, 50). CAV2-PRS-stGtACR2-fRed was 
injected (0.69 × 109 to 1.38 × 109 PP in total) under recovery anes-
thesia [ketamine (50 mg/kg; Vetalar; Pharmacia) and medetomidine 
(300 g/kg; Domitor; Pfizer)] at postnatal day 21. After burr hole 
formation, a dorsoventral injection track for a vector-filled, pulled 
glass pipette (tip diameter, 20 to 30 m) was started at 1 mm lateral 
and 1 mm posterior to lambda with 10° rostral angulation. Four 
injections of 250 nl of vector were made at depths from −4.6 to 
−5.5 mm unilaterally to the LC. Rats were terminally anesthetized 
with isoflurane (5%) 14 to 21 days later and decapitated, and the 
brain was quickly removed and immediately chilled in ice-cold cutting 
solution (similar to the recording solution, but NaCl was reduced to 
85 mM and substituted with sucrose 58.4 mM). Transverse slices (300 to 
350 m thick) of the pons were cut from dorsal to ventral using a 
vibratome (Linearslicer Pro 7; DSK) in cold (4°C) cutting solution.
After cutting, slices were kept at room temperature in carbogenated 
recording solution [126 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 
1.25 mM NaH2PO4, 2 mM MgCl2, 2 mM CaCl2, and 10 mM d-glucose 
saturated with 95% O2/5% CO2 (pH 7.3); osmolality, 290 mosmol/liter] 
for at least 1 hour to recover before recording. Pontine slices were 
transferred into the recording chamber of an upright fluorescence 
microscope (DMLFSA; Leica Microsystems), superfused with 
artificial cerebrospinal fluid at a rate of 4 to 8 ml/min heated to 35°C. 
Borosilicate glass patch pipettes (Harvard Apparatus GC120F-10, 
resistances of 3 to 6 megaohms) were filled with internal solution 
(130 mM K-gluconate, 10 mM KCl, 10 mM Na-Hepes, 4 mM 
MgATP 4, 0.2 mM EGTA, and 0.3 mM Na2GTP). Cells were identi-
fied under gradient contrast illumination and examined for trans-
duction by epifluorescence illumination. Blue light [473 nm, Doric 
light-emitting diode (LED), 4 mW] was pulsed onto slices from an 
optical fiber (400-m diameter) placed above the LC. Whole-cell 
voltage and current-clamp recordings were obtained with a Multi-
clamp 700A amplifier (Axon Instruments). All membrane potentials 
were corrected for a junction potential of 13 mV. The reversal 
potential for chloride ions using this combination of internal and 
external solutions was calculated as −68.7 mV. Data were acquired 
using a Power1401 A-D converter (CED) and displayed and analyzed 
with Spike2 software (CED, Cambridge Electronic Design).
Chronic experiments
In all chronic experiments, epidural EEGs (filtered 0.1 to 100 Hz), 
muscle tone EMG (filtered 10 to 100 Hz), and infrared video (except 
for in optogenetic experiment) were continuously recorded using a 
TDT RZ2 electrophysiology system, PZ amplifier, and RV2 video 
capture system (for pharmacological experiments) from Tucker Davis 
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Technologies (TDT), USA. For chronic LC recordings, a 16-channel 
linear silicon probe (177 M2 contact surface area, 100 M between 
adjacent contacts; NeuroNexus, USA) mounted on a micro-drive 
was implanted above the LC (AP,  −3.7 mm; ML, +1.15 to 1.18 mm; 
DV, 5.8 to 7.2 mm). After recovery and auditory habituation, the 
chronic micro-drive electrode was lowered 50 to 200 m daily under 
light isoflurane sedation until we succeeded in recording from 
neurons responding to toe pinch stimulation. In total, we recorded 
16 clusters from three rats (rat 1: nine clusters; rat 2: two clusters; 
and rat 3: five clusters).
Acute recordings
For acute opto-excitation recording, 3 weeks after viral vector injec-
tion, an optrode was lowered progressively in the LC [same electrode 
specifications as in chronic experiment (see above), coupled with a 
100-m core diameter optic fiber mounted 100 m above the top 
electrode contact; NeuroNexus, USA].
For acute opto-silencing recordings, rats were anesthetized with 
urethane at a dose of 1.5 mg/kg body weight and fixed in a stereo-
taxic frame. Isoflurane (at 1 to 2%) was also initially used as a sup-
plement to urethane for the craniotomy surgery. Two craniotomies 
were made, each consisting of a “window” of side length between 
0.5 and 1 mm centered on target coordinates from lambda AP −2.1 mm, 
ML, 1.2 mm and AP +1.4, ML 1.2 mm. A tapered fiber optic (OptogeniX, 
type Lambda-B) was inserted via the caudal window at a 10° rostral 
angulation to a depth of ~5.5 mm from the surface of the brain. 
A 32-channel silicon recording probe (NeuroNexus, A1x32-Poly2-
10mm-50s-177) was then inserted using a Narishige hydraulic 
manipulator (MWS31) via the rostral craniotomy, at an angle of 
−20° to depths of up to 8 mm from the brain surface. The probe 
signal was digitized using a 32-channel headstage (RHD2132, INTAN); 
the resulting signal was acquired and displayed using the Open Ephys 
recording system (51). LC neurons were identified initially by their 
pattern of spontaneous discharge (0.2 to 5 Hz); large-amplitude 
long-duration action potentials; and their biphasic response to 
hindpaw pinch (17). Once the LC was identified, the field was then 
illuminated (445 nm, 15 mW at the tip, Omicron PhoxX laser), and 
the effect on spike discharge was examined. Post hoc histological 
examination confirmed the position of the recording probe in the LC.
Optogenetic laser parameters
Blue stimulation at 447 nm for optogenetic excitation and silencing 
was delivered via lasers (CNI, China) coupled to optic fibers whose 
timing and intensity were automatically controlled via RZ2 (TDT). 
Light intensity at optic fiber tips was measured with a power meter 
(ThorLabs PM100D) before optic fiber insertion. Before starting 
opto-activation arousal threshold experiments (Fig. 4), we confirmed 
effective LC opto-excitation in each animal by verifying that strong 
laser stimulation (10 s at 10 Hz, 90-ms pulse duration, 20 mW) 
evoked reliable EEG desynchronization and sleep-wake transitions 
(Fig. 3C), as shown in (8, 9). Only rats that woke up from sleep in 
response to strong laser stimulation were included in subsequent 
experiments with auditory stimulation. Next, we adjusted the laser 
stimulation parameters (total duration, 3 s; pulse duration, 10 to 
30 ms), such that laser stimulation alone did not reliably affect 
awakening probability.
Auditory stimulation
All experiments were conducted in a double-wall sound-attenuating 
acoustic chamber (Industrial Acoustics Company, Winchester, UK). 
All sounds were stereo signals programmed in MATLAB, where 
one channel (containing a 1-s 4-kHz tone pip) was routed to the 
mono speaker in the chamber and the other channel was routed to 
the electrophysiology acquisition system. The sounds were trans-
duced into voltage signals by a high-sampling rate (192 kHz) sound 
card (LynxTWO, Lynx, USA), amplified (SA1, TDT), and played 
free field through a magnetic speaker (MF1, TDT) mounted 35 cm 
above the animal. For optogenetic experiments, where precise syn-
chronization between auditory and laser stimulation was required, 
sounds were digitally loaded from a PC and routed to the mono speaker 
via a TDT RZ2 system (TDT, USA). Tone pips played during arousal 
threshold experiments were with intensities in the range of 50- to 
98-dB SPL with intervals of 55 to 105 s with ±15-s jitter (the louder 
the sounds were, the higher the interval was between sounds). Sound 
intensity levels (dB SPL) were measured at cage floor height.
Systemic pharmacology
For systemic pharmacology experiments (Fig. 1, C and D, and 
fig. S1), either detomidine (1 mg/kg; 2 agonist to reduce NE levels), 
yohimbine (1 mg/kg; 2 antagonist to increase NE levels), or saline 
(0.9% NaCl; 1 ml/g) was injected intraperitoneally in pseudorandom 
order, while rats were lightly sedated with isoflurane. Recordings and 
acoustic stimulation started 15 to 20 min after the injection.
Combined arousal threshold and optogenetic experiments
In opto-activation experiment, we used three separate experimental 
paradigms (on different days) to evaluate the effects of laser stimu-
lation with pulses applied at either 5 Hz, 10 Hz, or “burst mode,” 
where 10 pulses were delivered at 20 Hz, repeated every second for 
3 s. Sounds consisted of 1-s 4-kHz tone pips presented at either 67- 
or 80-dB SPL. Each experiment lasted ~12 hours and included three 
conditions (Fig. 4A): (i) a “sound-only” condition (S), where tone 
pips were presented alone; (ii) a “sound with laser” condition (SL), 
where tone pips were presented during the last second of laser stim-
ulation; and (iii) a “laser-only” condition (L), where laser stimula-
tion was delivered without sounds. We recorded from eight rats 
expressing ChR-mCherry and from seven rats expressing mCherry 
only (total of 66 sessions; each session ~12 hours long).
In opto-silencing experiment, each experiment included three 
conditions: (i) a “sound-only” condition (S), where tone pips were 
presented alone; (ii) a “sound after laser” condition (“SafterL”), where 
tone pips were presented 2 s after laser onset; and (iii) a “sound with 
laser” condition (SL), where tone pips were presented simultaneously 
with the laser onset. Laser was applied for 5 s continuously. Each 
condition (S, SL, and SafterL) was compared to the other condition 
of the same-day session. We recorded from six rats expressing 
stGtACR2-fRed and five rats expressing mCherry only (total of 
37 sessions; each session ~12 hours long).
Pupillometry
Rats were anesthetized with 1.5% isoflurane and placed in a stereotaxic 
frame. An optic fiber connected the implanted optic fiber ferrule to 
the 473-nm laser. The eye was illuminated with an infrared light 
and monitored continuously with a vision color camera (VGAC; 
TDT) synchronized to a dedicated RV2 video processor (TDT), allow-
ing frame-by-frame synchronization between video data (30 frames/s) 
and laser stimulation. We examined the effects of different pulse dura-
tions (10 to 90 ms) on pupil size. For LC activation (Fig. 3, J to L), 
we applied unilateral laser stimulation to the LC while recording 
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from the contralateral pupil. For LC silencing (Fig. 5, E and F), we 
applied bilateral laser stimulation while recording from the left eye 
followed by the right eye, and then averaged the pupil size change of 
the two eyes. In control experiments, we applied unilateral (control 
for opto-excitation) or bilateral (control for opto-silencing) laser 
stimulation to the LC.
Histology
Tissue collection and fixation
Following all experiments (except acute silencing experiments), rats 
were perfused intracardially with saline (0.9% NaCl; 1 ml/g) followed 
by 4% paraformaldehyde (Merck) under deep isoflurane anesthesia. 
Brains were then extracted and fixed for 24 to 48 hours in 4% para-
formaldehyde. Coronal brain sections were cut using Leica VT1000 
S vibrating blade microtome at 50 m. Then, sections were either 
kept free floating in phosphate-buffered saline (PBS) for immuno-
histochemistry or mounted on glass slides and examined under 
bright-field microscopy. Following acute silencing experiments, rats 
were killed with an overdose of pentobarbital (Euthatal; 20 mg/100 g 
via intraperitoneal injection) and perfused transcardially with 0.9% 
NaCl followed by 4% formaldehyde in 0.1 M phosphate buffer (PB). 
Brains were removed and postfixed overnight before cryoprotection 
in 30% sucrose in 0.1 M PB. Sagittal tissue sections were then cut at 
40-m intervals using a freezing microtome.
Immunohistochemistry
The viral vector expression efficacy and specificity were evaluated 
histologically by double staining of free-floating sections. To this 
end, following all experiments (except acute silencing experiments), 
sections were washed three times in PBS (Hylabs) and then perme-
abilized in PBST (PBS containing 0.1% Triton X-100; Merck). Next, 
sections were blocked in PBST containing 20% NGS (normal goat 
serum; Vector Laboratories) for 1 hour at room temperature and 
incubated with primary antibodies in PBST (containing 2% NGS) at 
4°C for 24 to 36 hours. Primary antibodies were either against TH 
(chicken anti-TH, 1:500; ab76442, Abcam) and mCherry (mouse 
anti-mCherry, 1:500; ab125096, Abcam) for activation or against 
dopamine beta hydroxylase (mouse anti-DBH, 1:500; MAB308, Merck 
Millipore) and fRed (rabbit anti-tRFP, 1:500; AB233, Evrogen) for 
silencing. After three washes in PBS, sections were incubated with 
secondary antibodies conjugated to fluorophores [either Alexa Fluor 
488 goat anti-chicken (1:1000; ab150173, Abcam) and Alexa Fluor 
594 goat anti-mouse( 1:1000; ab150120, Abcam) for activation, or 
Alexa Fluor 488 goat anti-mouse (1:1000; ab150117, Abcam) and 
Alexa Fluor 594 goat anti-rabbit (1:1000; ab150080, Abcam) for 
silencing] in PBST containing 2% NGS for 1.5 hours at room tem-
perature. After three washes in PBS and once in PBST, sections were 
mounted onto glass slides and coverslipped with aqueous mounting 
medium (Thermo Scientific, catalog no. 9990412). Following acute 
silencing experiments, sections were mounted on slides and perme-
abilized in 0.1 M PB containing 0.3% Triton X-100 (Sigma) and then 
blocked for 45 min in 0.1 M PB containing 0.3% Triton X-100 (Sigma) 
and 5% NGS (Sigma). Sections were then incubated on-slide with 
primary antibodies against DBH [mouse anti-DBH, 1:2000; MAB308, 
Millipore (Chemicon)] and fRed (rabbit anti-tRFP, 1:500; AB233, 
Evrogen) in PB containing 5% goat serum and 0.3% Triton X-100 
for 16 hours. After removal of primary antibodies, tissue sections were 
washed twice in PB and then incubated with appropriate secondary 
antibodies conjugated to fluorophores (Alexa Fluor 488 goat anti- 
mouse and Alexa Fluor 594 goat anti-rabbit, both at 1:1000 dilution) 
in PB containing 0.3% Triton X-100 and 5% NGS at room temperature 
for 4 hours. Sections were again washed twice in PB and coverslipped 
with FluorSave mounting medium.
Fluorescence microscopy
Images were acquired by a Leica STED high-resolution laser scan-
ning confocal microscope (Leica, Wetzlar, Germany) and a 20 oil/1.4 
NA objective. Quantification of extent of colocalization was carried 
out by Imaris software (Bitplane, Zurich, Switzerland).
For histology of rats used in acute silencing experiments, images 
were acquired by Zeiss Axisoskop2 with pE2 LED excitation system 
(CoolLED, UK) and analyzed using a Zeiss Axiocam and AxioVision 
software. For tissue from acute optogenetic silencing experiments, 
images were acquired using a Leica DMI6000 inverted epifluorescence 
microscope equipped with Leica DFC365FX monochrome digital 
camera and Leica LAS-X acquisition software.
Data analysis
Sleep staging and awakenings
Wakefulness was defined by low-amplitude, high-frequency EEG 
activity, co-occurring with high tonic EMG activity with occasional phasic 
EMG bursts. In chronic LC recording experiments, we divided the wake-
fulness epochs between active wake (grooming, eating, and exploration) 
and quiet wake based on video recording. NREM sleep was defined by 
high-amplitude, low-frequency EEG, co-occurring with reduced EMG tone. 
REM sleep was defined by low-amplitude, high-frequency EEG dominated 
by posterior theta activity co-occurring with flat EMG, as in (47).
In arousal threshold experiments, each experimental trial was 
visually inspected, and those occurring during sleep were categorized 
as either eliciting behavioral awakening or maintained sleep. Behavioral 
awakening was declared if wake-like EEG flattening (without dominant 
theta) was present within 3 s from sound onset and lasted for at least 3 s. 
A substantial percentage of such intervals was accompanied by EMG 
changes (fig. S3), but these did not constitute a necessary condition 
because changes in neck EMG were not always present, even in cases 
where video showed clear awakening. When laser was presented alone, 
behavioral awakening was declared if the changes described above 
occurred in the same 3 s. Arousals could be followed by a wake period 
or by return to sleep (Fig. 1A). All other trials were categorized as 
maintained sleep.
Arousal threshold analysis
We compared awakening probability across sound intensities for 
NREM sleep and REM sleep separately (Fig. 1B), between drugs for 
the three sound intensities and sleep stages separately (Fig. 1D), and 
as a function of time elapsed after drug injection (fig. S1A).
In combined arousal threshold and optogenetic experiments, 
awakening probability was computed separately for NREM sleep and 
REM sleep, across conditions (S/SL/L), and across sound intensities 
(67/80-dB SPL). Specific conditions with less than 15 trials per con-
dition (e.g., 67-dB SPL in REM sleep) were excluded from analysis.
To assess true synergism between NE activity and sounds above and 
beyond their expected independent effects, we calculated the expected 
cumulative effect of the sound alone and the laser alone as follows: 
%S + (100 − %S) × (%L)/100 (where %S is the awakening percentage 
for sound only, and %L is the awakening percentage for laser alone; 
see horizontal lines in Fig. 4B). We then compared it to the observed 
awakening probability in the SL condition via two-way repeated- 
measures (RM) ANOVA [between conditions (S/SL) and laser param-
eters (5 Hz/10 Hz/burst) in NREM and REM sleep followed by 
paired t test corrected with false discovery rate; Fig. 4 and fig. S2].
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EEG and EMG analyses
To calculate the time-varying amplitude of the EEG in specific fre-
quency bands (0.5 to 4 Hz for delta and 5 to 9 Hz for theta), a notch 
filter was first applied around 50 Hz, and then the instantaneous 
amplitude was obtained by taking the absolute value of the Hilbert 
transform of the band-passed signal. Amplitude signals were then 
smoothed by a moving average filter (with 0.5-s window) and nor-
malized using z score relative to the baseline (2 s before sound). We 
then averaged the amplitude after the sound (0 to 6 s) and compared 
between trials followed by awakenings and trials followed by maintained 
sleep. We analyzed the EMG signal by first normalizing using z score 
and calculated the increase in the root mean square (RMS) after the 
sound (0 to 6 s) compared with the RMS of the baseline EMG activity 
(2 s before sound) in trials followed by awakenings versus trials fol-
lowed by maintained sleep. We calculated the fast Fourier transform 
(FFT) of baseline EEG activity for each trial and found decrease in 
delta power (0.5 to 4 Hz) in trials followed by awakenings compared 
with trials followed by maintained sleep. These comparisons were 
done via one-tailed paired t test for n = 9 rats (three from ChR2- 
mCherry, three from mCherry, and three from stGtACR2-fRed). We 
also calculated the FFT of baseline EEG activity for the silencing 
chronic experiment and found increase in delta power (0.5 to 4 Hz) 
in trials with laser compared with trials without laser. These com-
parisons were done via one-tailed paired t test for n = 17 sessions 
(six rats injected with stGtACR2-fRed).
Sleep spindles
Individual spindles were detected automatically in the EEG as in (23). 
Briefly, we identified events >2 SD over the mean of the 10- to 16-Hz 
band-pass–filtered signal and verified that increased power was 
specific to this range and not broadband. We then counted the 
number of spindle peaks that occurred in the 1.5 s before sound 
onset and compared laser on trials to laser off trials via paired t test.
Locomotor activity analysis
Rat position and movement were analyzed with a custom video 
software written in MATLAB that determines the animal’s center of 
mass and movement based on subtraction of consecutive images. 
After initial input from the user [who marks the initial animal location 
via a dedicated graphical user interface (GUI)], the software subtracts 
consecutive frames and, based on the number of pixels that were 
changed, estimates the degree of movement. Position and movements 
were compared between saline and yohimbine experiments via paired 
t tests (fig. S1D). We then calculated and compared the increase 
in locomotion time and distance traveled.
Pupillometry
To extract pupil area, video images were first cropped around the 
eye. A mask based on the median values was applied, and the best 
centrally fitted circle was selected using the “regionprops” function 
in MATLAB. For each trial separately, pupil area was normalized by 
the average baseline pupil area in the 1 s preceding trial onset, and 
percent change dynamics were calculated for the [−5 25]s interval 
around laser stimulation. Trials were then averaged for each animal 
and condition separately (~15 trials per condition) to generate time 
courses as seen in Fig. 3K. Statistically significant changes in pupil 
area in relation to baseline and between-parameters conditions 
(e.g., 70-ms versus 90-ms pulse duration) were evaluated via 
Wilcoxon signed-ranked test. The peak (trough) in pupil size was 
found by searching for the maximal (or minimal) value in the pupil 
size vector (excitation or silencing experiments, respectively) between 
1 s before laser offset and 4 s after laser offset.
Unit identification and spike sorting
Neuronal clusters were identified using the “wave_clus” software 
package (52) as described previously. For acute activation record-
ings, extracellular recordings were high-pass filtered above 300 Hz, 
and then a threshold at 5 SD above the median noise level was com-
puted (for chronic recordings, a similar threshold was set manually). 
Then, detected events were clustered using superparamagnetic cluster-
ing and were categorized as noise or neuronal clusters. For acute 
inhibition recordings, units were identified using the KiloSort 
clustering package (53). The Python-based clustering package Phy 
(https://github.com/kwikteam/phy-contrib) was then used to manually 
curate Kilosort output to select only well-isolated single units with 
clear refractory periods and to remove artifacts.
Analysis of spiking activity
For analysis of spontaneous (Fig. 2B) and sound-evoked (Fig. 2C) 
LC activity, data were first divided into vigilance states (active quiet, 
quiet wake, NREM sleep, NREM-REM sleep transitions, and REM 
sleep) according to EEG, EMG, and video (see above). Baseline tonic 
activity was calculated by averaging the firing rate 2 s before sound 
onset for each cluster and compared between states and within 
NREM sleep depending on whether the sound led to an awakening 
or not (Fig. 2, D and E). Percentage increase in awakening was cal-
culated as follows:  %Increase =  FR (awakenings − maintened sleep) _______________________   FR [max(awakening, maintened sleep ) ] × 100 . 
Sound-evoked firing was calculated by averaging the firing rate 
during the 100 ms after sound onset for each cluster and compared 
between states (Fig. 2C). All comparisons were done via a paired t test.
SUPPLEMENTARY MATERIALS
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